194 related articles for article (PubMed ID: 34974132)
21. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
[TBL] [Abstract][Full Text] [Related]
22. NLRC5 deficiency has a moderate impact on immunodominant CD8
Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
[TBL] [Abstract][Full Text] [Related]
23. NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
Yoshihama S; Vijayan S; Sidiq T; Kobayashi KS
Trends Cancer; 2017 Jan; 3(1):28-38. PubMed ID: 28718425
[TBL] [Abstract][Full Text] [Related]
24. NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2.
Zhu B; Ouda R; Kasuga Y; de Figueiredo P; Kobayashi KS
Bioessays; 2024 Apr; 46(4):e2300109. PubMed ID: 38461519
[TBL] [Abstract][Full Text] [Related]
25. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
26. Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.
Robbins GR; Truax AD; Davis BK; Zhang L; Brickey WJ; Ting JP
J Biol Chem; 2012 Jul; 287(29):24294-303. PubMed ID: 22645137
[TBL] [Abstract][Full Text] [Related]
27. NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity.
Santharam MA; Shukla A; Levesque D; Kufer TA; Boisvert FM; Ramanathan S; Ilangumaran S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108368
[TBL] [Abstract][Full Text] [Related]
28. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.
Li X; Guo F; Liu Y; Chen HJ; Wen F; Zou B; Li D; Qin Q; Liu X; Shen Y; Wang Y
Oncol Lett; 2015 Sep; 10(3):1533-1540. PubMed ID: 26622704
[TBL] [Abstract][Full Text] [Related]
29. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
31. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
Chelbi ST; Dang AT; Guarda G
Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
[TBL] [Abstract][Full Text] [Related]
32. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
[TBL] [Abstract][Full Text] [Related]
33. NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling.
Li Q; Wang Z; Zhang Y; Zhu J; Li L; Wang X; Cui X; Sun Y; Tang W; Gao C; Ma C; Yi F
Kidney Int; 2018 Sep; 94(3):551-566. PubMed ID: 29907459
[TBL] [Abstract][Full Text] [Related]
34. Neuronal NLRC5 regulates MHC class I expression in Neuro-2a cells and also during hippocampal development.
Li P; Shen Y; Cui P; Hu Y; Zhang Y; Miao F; Zhang A; Zhang J
J Neurochem; 2020 Jan; 152(2):182-194. PubMed ID: 31549732
[TBL] [Abstract][Full Text] [Related]
35. Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3.
Huang S; Li Y; Sheng G; Meng Q; Hu Q; Gao X; Shang Z; Lv Q
Cell Biol Int; 2021 May; 45(5):1050-1059. PubMed ID: 33438275
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
Yoo JS; Sasaki M; Cho SX; Kasuga Y; Zhu B; Ouda R; Orba Y; de Figueiredo P; Sawa H; Kobayashi KS
Nat Commun; 2021 Nov; 12(1):6602. PubMed ID: 34782627
[TBL] [Abstract][Full Text] [Related]
37. NLRC5: new cancer buster?
Tang F; Xu Y; Zhao B
Mol Biol Rep; 2020 Mar; 47(3):2265-2277. PubMed ID: 31925644
[TBL] [Abstract][Full Text] [Related]
38. Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.
Zhao MZ; Sun Y; Jiang XF; Liu L; Liu L; Sun LX
Immunol Res; 2019 Dec; 67(6):497-504. PubMed ID: 31900803
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity.
Zebertavage LK; Alice A; Crittenden MR; Gough MJ
Sci Rep; 2020 Apr; 10(1):7376. PubMed ID: 32355214
[TBL] [Abstract][Full Text] [Related]
40. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.
Tong Y; Cui J; Li Q; Zou J; Wang HY; Wang RF
Cell Res; 2012 May; 22(5):822-35. PubMed ID: 22473004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
